Literature DB >> 6860513

Limitation of enzymatic models for predicting myocardial infarct size.

K Thygesen, M Hørder, P H Petersen, B L Nielsen.   

Abstract

The possibility of predicting myocardial infarct size from early enzyme measurements was studied using a physiological two compartment distribution model. Based on this the time dependent appearance function in plasma was calculated for creatine kinase, aspartate aminotransferase, and lactate dehydrogenase in 29 patients suffering from acute myocardial infarction. On average, the appearance function of the three enzymes started four hours after the onset of symptoms, and the maximum was reached after 12 hours for creatine kinase, 13 hours for aspartate aminotransferase, and 22 hours for lactate dehydrogenase. The cumulated appearance function was used as an acceptable estimate of infarct size. The prediction of infarct size from defined points of the appearance function curve for each of the three enzymes was attempted according to a set schedule during the first 25 hours after the onset of myocardial infarction. The prediction using creatine kinase was superior to the other enzymes. Even so, a reliable prediction could only be established at the very earliest from nine hours and this is too late, as irreversible loss of myocardium occurs rapidly after the onset of symptoms. This, together with the fact that other models have unacceptable variability of the prediction, lead to the conclusion that enzymatic predictive models are of no practical value in clinical intervention studies to reduce infarct size.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6860513      PMCID: PMC481373          DOI: 10.1136/hrt.50.1.70

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  19 in total

1.  A sensitivity analysis of enzymatic estimation of infarct size.

Authors:  C R Roe; C F Starmer
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

2.  Usefulness of ST segment elevations as predictors of electrocardiographic signs of necrosis in patients with acute myocardial infarction.

Authors:  J Askenazi; P R Maroko; M Lesch; E Braunwald
Journal:  Br Heart J       Date:  1977-07

Review 3.  Analysis of disappearance time-curves after single injection of labelled proteins.

Authors:  B Nosslin
Journal:  Ciba Found Symp       Date:  1972

4.  Attempt to quantitate relation between cardiac function and infarct size in acute myocardial infarction.

Authors:  D Mathey; W Biefield; P Hanrath; S Effert
Journal:  Br Heart J       Date:  1974-03

5.  Serum enzyme determinations in the diagnosis and assessment of myocardial infarction.

Authors:  B E Sobel; W E Shell
Journal:  Circulation       Date:  1972-02       Impact factor: 29.690

6.  An improved basis for enzymatic estimation of infarct size.

Authors:  R Roberts; P D Henry; B E Sobel
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

7.  Quantitation of infarct size in man by means of plasma enzyme levels.

Authors:  S A Witteveen; H C Hemker; L Hollaar; W T Hermens
Journal:  Br Heart J       Date:  1975-08

8.  Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.

Authors:  R M Norris; R M Whitlock; C Barratt-Boyes; C W Small
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

9.  Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.

Authors:  W E Shell; J F Lavelle; J W Covell; B E Sobel
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

10.  Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.

Authors:  W E Shell; J K Kjekshus; B E Sobel
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.